biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > The Roadshows. Question Everything, Including Nothing.

<< Previous

Bullboard Posts

Next >>

Comment by Sniper007on Jun 09, 2022 12:57pm

157 Views

Post# 34744175

RE:RE:The Roadshows. Question Everything, Including Nothing.

Thanks for taking the time to write that valuable piece, JD. Some tough questions to be asked for sure, and hopefully answered.

Unfortunately for me, it looks like I will be unable to attend the roadshow in Vancouver. That said, I'm hopeful someone can ask these tough questions and share with the board the answers, or lack thereof. It is indeed part of the public record.

If anyone does attend the road show, please keep in mind, only 2 hours have been scheduled for shareholders.

The time for Bioasis accountability, and ultimately, judgement, is rapidly approaching.

<< Previous

Bullboard Posts

Next >>

Options trading in a volatile macro environment